LONDON -- Takeda Pharmaceutical confirmed Thursday that it seeks to buy Shire, though the Irish drugmaker -- whose market value trumps that of its Japanese peer -- agreed only to talks with the suitor after finding its proposal unsatisfactory.
Japan's biggest drugmaker by sales proposes buying all of Shire for 42.7 billion pounds ($60.7 billion) in cash and stock, according to a company statement.